亚洲社会药学 ›› 2023, Vol. 18 ›› Issue (3): 247-251.

• • 上一篇    下一篇

Effect of the Policies to Prevent Drug Shortage and Stabilize Drug Prices in Medical Institutions

  

  • 出版日期:2023-09-25 发布日期:2023-09-23

Effect of the Policies to Prevent Drug Shortage and Stabilize Drug Prices in Medical Institutions

  • Online:2023-09-25 Published:2023-09-23

摘要:

Objective To evaluate the effect of some policies to prevent drug shortage and stabilize drug prices, and to provide reference for improving relevant policies. Methods With a combination of random stratified sampling and quota sampling, 532 medical institutions in 20 provinces were selected to carry out questionnaire surveys. Then, a comparative analysis was made to study the changes of drugs on the shortage list and drugs on non-shortage list before and after the release of the policy of ensuring supply and stabilizing prices. Results and Conclusion The policy played an important role in curbing the growth of drug shortage in the medical institutions, but it did not curb the growth of drugs on non-shortage list. Besides, the drugs on non-shortage list showed an overall fluctuation and upward trend. Meanwhile, from the perspective of drug prices, the price stability problem of drugs on the shortage list and on the non-shortage list became more serious, and the average price increase was 256% and 239%, respectively. The implementation of policies related to the supply and price stability of drugs prevents the growth trend of drug shortages in the list of medical institutions, which has been recognized by most medical institutions. However, there is an increasing trend in the number of drugs on non-shortage list. In addition, the price increase of drugs on both the shortage list and non-shortage list is severe. Some medical institutions report that they have difficulties in using the information reporting system of drug shortage and the classification, grading and the alternative use of drug shortages. It is recommended to strengthen the management of price stabilization of drugs on the shortage list. Further attention should be paid to the supply and price stabilization of drugs on non-shortage list. At the same time, trainings in the classification and substitution of drug shortage and information reporting system should be actively organized, thus comprehensively improving the capabilities of medical institutions at all levels to deal with the problem of drug shortage.

关键词:

Abstract: Objective To evaluate the effect of some policies to prevent drug shortage and stabilize drug prices, and to provide reference for improving relevant policies. Methods With a combination of random stratified sampling and quota sampling, 532 medical institutions in 20 provinces were selected to carry out questionnaire surveys. Then, a comparative analysis was made to study the changes of drugs on the shortage list and drugs on non-shortage list before and after the release of the policy of ensuring supply and stabilizing prices. Results and Conclusion The policy played an important role in curbing the growth of drug shortage in the medical institutions, but it did not curb the growth of drugs on non-shortage list. Besides, the drugs on non-shortage list showed an overall fluctuation and upward trend. Meanwhile, from the perspective of drug prices, the price stability problem of drugs on the shortage list and on the non-shortage list became more serious, and the average price increase was 256% and 239%, respectively. The implementation of policies related to the supply and price stability of drugs prevents the growth trend of drug shortages in the list of medical institutions, which has been recognized by most medical institutions. However, there is an increasing trend in the number of drugs on non-shortage list. In addition, the price increase of drugs on both the shortage list and non-shortage list is severe. Some medical institutions report that they have difficulties in using the information reporting system of drug shortage and the classification, grading and the alternative use of drug shortages. It is recommended to strengthen the management of price stabilization of drugs on the shortage list. Further attention should be paid to the supply and price stabilization of drugs on non-shortage list. At the same time, trainings in the classification and substitution of drug shortage and information reporting system should be actively organized, thus comprehensively improving the capabilities of medical institutions at all levels to deal with the problem of drug shortage.

Key words: